By proceeding, you agree to our Terms of Use and Privacy Policy.
Join us at the Gaylord National Resort & Convention Center in Washington, D.C. from May 23-25, 2023 for the world's most important orphan drug and rare disease event. With over 1,200 attendees, 100+ sponsors and exhibitors, 250+ speakers, and 13 themes of content, the World Orphan Drug Congress is the premier forum for breaking down silos and fostering collaboration among rare disease stakeholders. Our conference brings together leading pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors, and solution providers, to advance orphan drug development and improve access to life-saving therapies. Join us for three days of comprehensive programming and inclusive networking opportunities, as we brainstorm and work towards solutions that help rare disease patients. Don't miss out on the chance to be part of the most significant gathering of rare disease stakeholders.
Discover the latest updates and developments in orphan drug development and research.
Gather deep knowledge on drug discovery, clinical development, rare disease advocacy, patient access, rare oncology, commercialization and many more.
Attend keynote sessions to explore approaches in AI and digital health span for the entire development life cycle of drug development and commercialization
Listen to top industry experts to learn cell and gene therapy manufacturing hurdles and how firms may effectively scale up for commercial production.
Terrapinn events inspire and transform business.We’ve been sparking ideas, innovations and relationships that transform business for over 30 years. Using our global footprint, we bring innovators, disrupters and change agents together.
Founded by physicians committed to advancing medical science, Worldwide is out to change how the world experiences CROs – in the best possible way.
Breakthroughs That Change Patients' Lives: Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend and significantly improve lives.
Parexel is focused on the development of innovative new therapies to improve the world’s health.
ICON plc is a global provider of outsourced drug development and commercialisation solutions and services to pharmaceutical, biotechnology, medical device, and government and public health organisations.
Durbin is one of the world’s leading specialist medical suppliers and an integral part of Uniphar’s Product Access division.
Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care.
Pharma Business Partners is a consulting and market research firm focusing on the life sciences sector. Whilst our experience is global, we focus on MEA related work to add true insights and value to our clients portfolios.
PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services.
At Janssen, we never stop working toward a future where disease is a thing of the past.
Our mission is to transform the lives of people living with rare diseases and devastating conditions through the development and delivery of innovative medicines, as well as through supportive technologies and healthcare services.
Premier Research is not about being everything to everyone. Instead, our deep, focused expertise targets the therapeutic areas and indications where today’s biotech and specialty pharma pioneers are doing the most amazing work.
Red Nucleus is the premier provider of strategic learning, performance, and process solutions exclusively for the life sciences industry.
Simon-Kucher is a global consultancy with more than 2,000 employees in 30 countries. Our sole focus is on unlocking better growth that drives measurable revenue and profit for our clients.
A leading Contract Research Organization (CRO) designed to navigate the complexity of trials in orphan indications.
EVERSANA™ is the leading provider of global services to the life sciences industry.
ProPharma Group is the global, independent, single-source provider of regulatory and compliance consulting, clinical research services, pharmacovigilance, and medical information serving pharmaceutical, biotechnology, and medical device companies.
Bionical Emas is a global Contract Research Organisation (CRO) business.
Allucent is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. The company is purpose-built through the convergence of leading providers to address this unmet need.
Clinigen has more than 30 years’ experience providing quicker and broader access to critical medicines in 120+ countries, pre- and post-launch.
Invitae is a leader in medical genetic testing, driving genetic information into mainstream medicine to improve healthcare for billions of people.
Pharmaceutical Development Company is a leading clinical research organization, providing the full range of Phase I to IV clinical development services.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.